157 related articles for article (PubMed ID: 8099533)
1. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas.
Satoh K; Sasano H; Shimosegawa T; Koizumi M; Yamazaki T; Mochizuki F; Kobayashi N; Okano T; Toyota T; Sawai T
Cancer; 1993 Jul; 72(1):51-6. PubMed ID: 8099533
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma.
Mukawa K; Kawa S; Aoki Y; Zhai Y; Nikaido T
Am J Gastroenterol; 1999 Aug; 94(8):2263-7. PubMed ID: 10445560
[TBL] [Abstract][Full Text] [Related]
3. C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia.
Porter PL; Garcia R; Moe R; Corwin DJ; Gown AM
Cancer; 1991 Jul; 68(2):331-4. PubMed ID: 1676930
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of Sonic hedgehog in intraductal papillary mucinous tumor of the pancreas.
Jang KT; Lee KT; Lee JG; Choi SH; Heo JS; Choi DW; Ahn G
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):294-8. PubMed ID: 17721274
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
[TBL] [Abstract][Full Text] [Related]
6. Expression of oncogene products, anti-oncogene products and oncofetal antigens in intraductal papillary-mucinous neoplasm of the pancreas.
Terada T; Ohta T; Nakanuma Y
Histopathology; 1996 Oct; 29(4):355-61. PubMed ID: 8910043
[TBL] [Abstract][Full Text] [Related]
7. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.
Osako M; Yonezawa S; Siddiki B; Huang J; Ho JJ; Kim YS; Sato E
Cancer; 1993 Apr; 71(7):2191-9. PubMed ID: 8384065
[TBL] [Abstract][Full Text] [Related]
9. Intraductal mucin-hypersecreting neoplasm "mucinous ductal ectasia": endoscopic recognition and management.
Tenner S; Carr-Locke DL; Banks PA; Brooks DC; Van Dam J; Farraye FA; Turner JR; Lichtenstein DR
Am J Gastroenterol; 1996 Dec; 91(12):2548-54. PubMed ID: 8946984
[TBL] [Abstract][Full Text] [Related]
10. Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.
van de Vijver MJ; Peterse JL; Mooi WJ; Wisman P; Lomans J; Dalesio O; Nusse R
N Engl J Med; 1988 Nov; 319(19):1239-45. PubMed ID: 2903446
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas.
Satoh K; Shimosegawa T; Moriizumi S; Koizumi M; Toyota T
Pancreas; 1996 May; 12(4):362-8. PubMed ID: 8740403
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
Sessa F; Solcia E; Capella C; Bonato M; Scarpa A; Zamboni G; Pellegata NS; Ranzani GN; Rickaert F; Klöppel G
Virchows Arch; 1994; 425(4):357-67. PubMed ID: 7820300
[TBL] [Abstract][Full Text] [Related]
14. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
Somerville JE; Clarke LA; Biggart JD
J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study.
Terada T; Ohta T; Kitamura Y; Ashida K; Matsunaga Y
Arch Pathol Lab Med; 1998 Jan; 122(1):42-6. PubMed ID: 9448015
[TBL] [Abstract][Full Text] [Related]
16. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
Kommoss F; Colley M; Hart CE; Franklin WA
Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 2001; 48(39):879-83. PubMed ID: 11462947
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas--diagnostic and biologic significance.
Islam HK; Fujioka Y; Tomidokoro T; Sugiura H; Takahashi T; Kondo S; Katoh H
Hepatogastroenterology; 1999; 46(28):2599-605. PubMed ID: 10522048
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]